Latest News and Press Releases

Ålesund/Miami, November 1st, 2019 Atlantic Sapphire AS (“Atlantic Sapphire”, ASA-ME) and Hofseth Biocare ASA (“HBC”; OSE:HBC) announce today the signing of a Letter of Intent to establish a joint...

Hofseth BioCare had operating revenues of NOK 29.2m (16.9m) in the third quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 25.3m (14.3m) in the period. Operational profit (EBITDA) for...

Hofseth BioCare ASA ("HBC") has entered into a consultancy agreement with Dr. Crawford Currie to strengthen the IR and communications functions of HBC. Dr. Currie is based in London and is a...

Hofseth BioCare ASA ("HBC") has today entered into a consultancy agreement with James Berger (through his company Nevera AG). Mr. Berger is a dual British and Italian citizen currently residing in...

Hofseth BioCare ASA ("HBC") has today entered into a consultancy agreement with James Berger (through his company Nevera AG). Mr. Berger is a dual British and Italian citizen currently residing in...

Reference is made to the stock exchange notice issued on 30 August 2019 regarding the Second Quarter 2019 Financial Report. The section “Declaration by the Board of Directors and CEO” is missing...

Reference is made to the subsequent offering of up to 1,500,000 new shares (the "Subsequent Offering") in Hofseth BioCare ASA, and the stock exchange notice issued on 18 September 2019 regarding the...

Hofseth BioCare ASA (HBC) is pleased to announce the grant of its patent no. 3399871; “A new method to improve enzyme hydrolysis and resultant protein flavor and bio-activity of fish offcuts”, with...

Hofseth BioCare ASA ("HBC" or the "Company") announces today that it has established a management incentive program (the "Program") with a total limit of 11,000,000 shares in the Company. The Program...

Reference is made to the stock exchange notice published on 2 September 2019 regarding a repair issue with gross proceeds of up to NOK 6 million directed towards eligible shareholders (the "Repair...